13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-12, with 54 holding rows worth $237,227,000.
- Accession
- 0001387131-22-008717
- Filer
- CIK 1773195
- Filed
- 2022-08-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2022
A holdings report, 54 entries on the cover page, a total value of $237,227,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $237,227,000 with VALUE read as thousands by filing date, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 359,956 | $19,574,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 928,256 | $17,015,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 937,568 | $16,398,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 222,173 | $15,106,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 125,087 | $11,628,000 | thousands by filing date | |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 11,000,000 | $10,901,000 | thousands by filing date | principal |
| Eli Lilly and Company | 532457108 | COM | 30,000 | $9,727,000 | thousands by filing date | call |
| LANTHEUS HLDGS INC | 516544103 | COM | 140,000 | $9,244,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 150,000 | $8,157,000 | thousands by filing date | put |
| NANOSTRING TECHNOLOGIES INC | 63009RAD1 | BOND | 10,000,000 | $8,019,000 | thousands by filing date | principal |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,000 | $7,158,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 75,000 | $5,982,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 45,000 | $5,693,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 45,000 | $5,693,000 | thousands by filing date | put |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 85,000 | $5,616,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 215,723 | $4,681,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 90,000 | $4,629,000 | thousands by filing date | put |
| LANTHEUS HLDGS INC | 516544103 | COM | 70,000 | $4,622,000 | thousands by filing date | put |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 493,278 | $4,558,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 321,200 | $4,494,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 85,000 | $4,372,000 | thousands by filing date | call |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 70,000 | $4,254,000 | thousands by filing date | call |
| Bridgebio Pharma Inc Note 2.250 percent 2/0 | 10806XAD4 | Convertible | 10,000,000 | $4,237,000 | thousands by filing date | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 7,500,000 | $4,154,000 | thousands by filing date | principal |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,372,244 | $4,048,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 145,000 | $3,909,000 | thousands by filing date | call |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 250,466 | $3,446,000 | thousands by filing date | |
| ARYA SCIENCES ACQUISITN CORP | G31658100 | CLASS A ORD SHS | 352,500 | $3,426,000 | thousands by filing date | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 50,000 | $2,750,000 | thousands by filing date | call |
| MODERNA INC | 60770K107 | COM | 15,000 | $2,143,000 | thousands by filing date | call |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 70,000 | $1,967,000 | thousands by filing date | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 883,654 | $1,873,000 | thousands by filing date | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 1,374,098 | $1,814,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 67,500 | $1,673,000 | thousands by filing date | call |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 150,000 | $1,656,000 | thousands by filing date | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 100,000 | $1,396,000 | thousands by filing date | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 75,000 | $1,356,000 | thousands by filing date | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 466,607 | $1,255,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 125,000 | $1,128,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 40,000 | $1,078,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 401,268 | $995,000 | thousands by filing date | |
| LIANBIO ADR | 53000N108 | COM | 450,000 | $972,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 170,000 | $721,000 | thousands by filing date | |
| CELULARITY INC | 151190105 | COM | 183,600 | $624,000 | thousands by filing date | put |
| CYTOKINETICS INC | 23282W605 | COM NEW | 15,000 | $589,000 | thousands by filing date | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 279,775 | $562,000 | thousands by filing date | |
| RENOVACOR INC | 75989E106 | COM | 199,490 | $405,000 | thousands by filing date | |
| Renovaro Inc | 29350E104 | Common Stock | 200,000 | $386,000 | thousands by filing date | put |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $382,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 340,349 | $335,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 20,660 | $239,000 | thousands by filing date | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 25,578 | $174,000 | thousands by filing date | |
| MEDICUS SCIENCES ACQUISITION | G5960S124 | *W EXP 02/12/202 | 33,333 | $8,000 | thousands by filing date | |
| Renovacor Inc | 75989E114 | Warrant | 75,000 | $5,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-22-008717 | this filing | 2022-08-12 | acceptance time not in the bulk data set |